Logo image of MTX

MINERALS TECHNOLOGIES INC (MTX) Stock Fundamental Analysis

NYSE:MTX - New York Stock Exchange, Inc. - US6031581068 - Common Stock - Currency: USD

59.1  +0.15 (+0.25%)

After market: 59.1 0 (0%)

Fundamental Rating

4

Taking everything into account, MTX scores 4 out of 10 in our fundamental rating. MTX was compared to 85 industry peers in the Chemicals industry. MTX has an average financial health and profitability rating. MTX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MTX had positive earnings in the past year.
In the past year MTX had a positive cash flow from operations.
MTX had positive earnings in each of the past 5 years.
Each year in the past 5 years MTX had a positive operating cash flow.
MTX Yearly Net Income VS EBIT VS OCF VS FCFMTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

MTX has a Return On Assets of -0.69%. This is in the lower half of the industry: MTX underperforms 64.71% of its industry peers.
MTX has a Return On Equity (-1.48%) which is comparable to the rest of the industry.
MTX has a Return On Invested Capital of 1.51%. This is in the lower half of the industry: MTX underperforms 70.59% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MTX is in line with the industry average of 6.84%.
The last Return On Invested Capital (1.51%) for MTX is well below the 3 year average (6.89%), which needs to be investigated, but indicates that MTX had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.69%
ROE -1.48%
ROIC 1.51%
ROA(3y)3.68%
ROA(5y)3.88%
ROE(3y)7.46%
ROE(5y)8.15%
ROIC(3y)6.89%
ROIC(5y)6.42%
MTX Yearly ROA, ROE, ROICMTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MTX's Profit Margin has been stable in the last couple of years.
The Operating Margin of MTX (2.72%) is worse than 71.76% of its industry peers.
In the last couple of years the Operating Margin of MTX has remained more or less at the same level.
MTX has a Gross Margin (25.60%) which is in line with its industry peers.
MTX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.72%
PM (TTM) N/A
GM 25.6%
OM growth 3Y1.32%
OM growth 5Y0.73%
PM growth 3Y-3.75%
PM growth 5Y1.26%
GM growth 3Y2.47%
GM growth 5Y1%
MTX Yearly Profit, Operating, Gross MarginsMTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MTX is destroying value.
The number of shares outstanding for MTX has been reduced compared to 1 year ago.
The number of shares outstanding for MTX has been reduced compared to 5 years ago.
MTX has a better debt/assets ratio than last year.
MTX Yearly Shares OutstandingMTX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MTX Yearly Total Debt VS Total AssetsMTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

MTX has an Altman-Z score of 2.45. This is not the best score and indicates that MTX is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.45, MTX is in the better half of the industry, outperforming 67.06% of the companies in the same industry.
MTX has a debt to FCF ratio of 11.63. This is a negative value and a sign of low solvency as MTX would need 11.63 years to pay back of all of its debts.
MTX has a Debt to FCF ratio of 11.63. This is in the better half of the industry: MTX outperforms 61.18% of its industry peers.
A Debt/Equity ratio of 0.61 indicates that MTX is somewhat dependend on debt financing.
MTX has a Debt to Equity ratio (0.61) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.63
Altman-Z 2.45
ROIC/WACC0.17
WACC8.71%
MTX Yearly LT Debt VS Equity VS FCFMTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.89 indicates that MTX should not have too much problems paying its short term obligations.
The Current ratio of MTX (1.89) is comparable to the rest of the industry.
A Quick Ratio of 1.31 indicates that MTX should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.31, MTX perfoms like the industry average, outperforming 56.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.31
MTX Yearly Current Assets VS Current LiabilitesMTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.13% over the past year.
Measured over the past 5 years, MTX shows a small growth in Earnings Per Share. The EPS has been growing by 7.77% on average per year.
MTX shows a decrease in Revenue. In the last year, the revenue decreased by -3.82%.
MTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.42% yearly.
EPS 1Y (TTM)4.13%
EPS 3Y7.07%
EPS 5Y7.77%
EPS Q2Q%-23.49%
Revenue 1Y (TTM)-3.82%
Revenue growth 3Y4.47%
Revenue growth 5Y3.42%
Sales Q2Q%-7.99%

3.2 Future

MTX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.81% yearly.
MTX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.50% yearly.
EPS Next Y-7.98%
EPS Next 2Y2.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.59%
Revenue Next 2Y1.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MTX Yearly Revenue VS EstimatesMTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
MTX Yearly EPS VS EstimatesMTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

MTX is valuated reasonably with a Price/Earnings ratio of 10.19.
Compared to the rest of the industry, the Price/Earnings ratio of MTX indicates a rather cheap valuation: MTX is cheaper than 88.24% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.45, MTX is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.09, the valuation of MTX can be described as very reasonable.
85.88% of the companies in the same industry are more expensive than MTX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, MTX is valued rather cheaply.
Industry RankSector Rank
PE 10.19
Fwd PE 9.09
MTX Price Earnings VS Forward Price EarningsMTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

MTX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MTX is more expensive than 63.53% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MTX is valued a bit cheaper than 68.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.11
EV/EBITDA 16.65
MTX Per share dataMTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.31
EPS Next 2Y2.81%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

MTX has a yearly dividend return of 0.79%, which is pretty low.
MTX's Dividend Yield is comparable with the industry average which is at 3.69.
With a Dividend Yield of 0.79, MTX pays less dividend than the S&P500 average, which is at 2.42.
Industry RankSector Rank
Dividend Yield 0.79%

5.2 History

On average, the dividend of MTX grows each year by 15.37%, which is quite nice.
MTX has paid a dividend for at least 10 years, which is a reliable track record.
MTX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.37%
Div Incr Years2
Div Non Decr Years31
MTX Yearly Dividends per shareMTX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

MTX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of MTX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-57.63%
EPS Next 2Y2.81%
EPS Next 3YN/A
MTX Yearly Income VS Free CF VS DividendMTX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

MINERALS TECHNOLOGIES INC

NYSE:MTX (7/3/2025, 7:51:38 PM)

After market: 59.1 0 (0%)

59.1

+0.15 (+0.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)07-24 2025-07-24/amc
Inst Owners99.67%
Inst Owner Change2.16%
Ins Owners1.15%
Ins Owner Change4.39%
Market Cap1.88B
Analysts80
Price Target82.96 (40.37%)
Short Float %2.13%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield 0.79%
Yearly Dividend0.41
Dividend Growth(5Y)15.37%
DP-57.63%
Div Incr Years2
Div Non Decr Years31
Ex-Date05-30 2025-05-30 (0.11)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.05%
Min EPS beat(2)-4.75%
Max EPS beat(2)6.85%
EPS beat(4)2
Avg EPS beat(4)0.89%
Min EPS beat(4)-4.75%
Max EPS beat(4)6.85%
EPS beat(8)6
Avg EPS beat(8)4.39%
EPS beat(12)8
Avg EPS beat(12)-0.24%
EPS beat(16)12
Avg EPS beat(16)0.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.55%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-2.47%
Min Revenue beat(4)-3.69%
Max Revenue beat(4)-1.18%
Revenue beat(8)1
Avg Revenue beat(8)-1.98%
Revenue beat(12)4
Avg Revenue beat(12)-1.01%
Revenue beat(16)5
Avg Revenue beat(16)-1.17%
PT rev (1m)-1.41%
PT rev (3m)-19.47%
EPS NQ rev (1m)0.12%
EPS NQ rev (3m)-19.73%
EPS NY rev (1m)-2.8%
EPS NY rev (3m)-13.5%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-5.32%
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)-3.96%
Valuation
Industry RankSector Rank
PE 10.19
Fwd PE 9.09
P/S 0.9
P/FCF 22.11
P/OCF 10.65
P/B 1.17
P/tB 4.01
EV/EBITDA 16.65
EPS(TTM)5.8
EY9.81%
EPS(NY)6.5
Fwd EY11%
FCF(TTM)2.67
FCFY4.52%
OCF(TTM)5.55
OCFY9.39%
SpS65.42
BVpS50.37
TBVpS14.74
PEG (NY)N/A
PEG (5Y)1.31
Profitability
Industry RankSector Rank
ROA -0.69%
ROE -1.48%
ROCE 2.01%
ROIC 1.51%
ROICexc 1.7%
ROICexgc 3.1%
OM 2.72%
PM (TTM) N/A
GM 25.6%
FCFM 4.09%
ROA(3y)3.68%
ROA(5y)3.88%
ROE(3y)7.46%
ROE(5y)8.15%
ROIC(3y)6.89%
ROIC(5y)6.42%
ROICexc(3y)7.67%
ROICexc(5y)7.18%
ROICexgc(3y)13.35%
ROICexgc(5y)12.39%
ROCE(3y)9.31%
ROCE(5y)8.65%
ROICexcg growth 3Y6.72%
ROICexcg growth 5Y4.56%
ROICexc growth 3Y6.7%
ROICexc growth 5Y3.44%
OM growth 3Y1.32%
OM growth 5Y0.73%
PM growth 3Y-3.75%
PM growth 5Y1.26%
GM growth 3Y2.47%
GM growth 5Y1%
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 11.63
Debt/EBITDA 6.48
Cap/Depr 96.21%
Cap/Sales 4.4%
Interest Coverage 0.9
Cash Conversion 116.39%
Profit Quality N/A
Current Ratio 1.89
Quick Ratio 1.31
Altman-Z 2.45
F-Score4
WACC8.71%
ROIC/WACC0.17
Cap/Depr(3y)93.37%
Cap/Depr(5y)131.49%
Cap/Sales(3y)4.14%
Cap/Sales(5y)6.45%
Profit Quality(3y)91.22%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.13%
EPS 3Y7.07%
EPS 5Y7.77%
EPS Q2Q%-23.49%
EPS Next Y-7.98%
EPS Next 2Y2.81%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.82%
Revenue growth 3Y4.47%
Revenue growth 5Y3.42%
Sales Q2Q%-7.99%
Revenue Next Year-1.59%
Revenue Next 2Y1.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-80.82%
EBIT growth 3Y5.84%
EBIT growth 5Y4.17%
EBIT Next Year21.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y64.98%
FCF growth 3YN/A
FCF growth 5Y-3.25%
OCF growth 1Y26.6%
OCF growth 3Y0.57%
OCF growth 5Y-0.16%